CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $358,130 | -72.8% | 6,610 | -58.1% | 0.06% | -64.2% |
Q4 2023 | $1,316,136 | +49.9% | 15,764 | -29.5% | 0.18% | +148.6% |
Q2 2022 | $878,000 | -20.3% | 22,347 | -25.3% | 0.07% | -21.7% |
Q1 2022 | $1,102,000 | -10.3% | 29,933 | +11.1% | 0.09% | -15.6% |
Q4 2021 | $1,228,000 | +15.5% | 26,948 | -9.4% | 0.11% | -14.2% |
Q3 2021 | $1,063,000 | – | 29,739 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |